[1] 刘佳,和茵,刘鑫. 肿瘤患者PICC导管相关性感染的危险因素及护理对策[J]. 昆明医科大学学报,2021,42(1):173-176. [2] 寿月华,王笑娟,徐芳娟. 化疗患者PICC导管相关性感染危险因素[J]. 中华医院感染学杂志,2020,30(16):2470-2473. [3] Thomsen SL, Boa R, Vinter-Jensen L, et al.Safety and efficacy of midline vs peripherally inserted central catheters among adults receiving IV therapy:A randomized clinical trial[J]. JAMA Netw Open, 2024, 7(2): e2355716. [4] 陈丽霞,叶艳菊,闫峰,等. 胃癌化疗患者PICC导管相关性感染易感因素及预测模型的构建[J]. 中华医院感染学杂志,2023,33(7):1112-1116. [5] Park EJ, Park K, Kim JJ, et al.Safety, efficacy, and patient satisfaction with initial peripherally inserted central catheters compared with usual intravenous access in terminally Ill cancer patients:A randomized phase II study[J]. Cancer Res Treat, 2021, 53(3): 881-888. [6] 韩梦玲,马逊,徐玮,等. 老年血液透析病人营养状况以及主观综合营养评估法与透析营养客观评分法评估效果比较[J]. 实用老年医学,2023,37(12):1242-1246. [7] 尚新芳,薛蓉,任丽平. 化疗患者留置经外周静脉置入中心静脉导管后导管相关性感染的危险因素[J]. 中国感染与化疗杂志,2022,22(2):151-155. [8] 解莹,徐馨,关惠允. 外周置入中心静脉导管术导管相关性感染现状及危险因素[J]. 华南预防医学,2021,47(1):124-127. [9] 孙舒君,刘元昉,叶雅静. 急性淋巴细胞白血病化疗患者经外周静脉穿刺的中心静脉导管相关性感染影响因素的logistic回归分析[J]. 癌症进展,2020,18(7):718-720,747. [10] 杨静,冯占春. 乳腺癌患者术后发生PICC导管相关性感染因素[J]. 中国临床研究,2022,35(9):1319-1323. [11] 李艳华,谢俊英,许丽娜,等. 肿瘤患者经外周静脉穿刺的中心静脉导管相关并发症分析[J]. 癌症进展,2023,21(1):37-40. [12] Mack V, Nißler D, Kasikci D, et al.Magnetic tracking and electrocardiography-guided tip confirmation system versus fluoroscopy for placement of peripherally inserted central catheters: A randomized, noninferiority comparison[J]. Cardiovasc Intervent Radiol, 2020, 43(12): 1891-1897. [13] 石春妮,袁丽,罗艳,等. 老年恶性肿瘤化疗患者PICC血流感染与患者预后的相关性研究[J]. 老年医学与保健,2022,28(1):115-119. [14] 卢威男,张春燕,蔺小霞,等. 结直肠癌患者中心静脉导管置管感染相关因素分析及预防措施[J]. 实用医院临床杂志,2020,17(1):116-119. [15] 周媛,骆煜,胡琳琳,等. 乳腺癌患者术后PICC导管相关性感染的危险因素及血清C反应蛋白、降钙素原对感染发生风险的预测价值[J]. 现代生物医学进展,2023,23(2):289-293,288. [16] 郝其艳,王炜. 肺癌化疗患者发生导管相关性血流感染的影响因素及其风险预测列线图模型构建[J]. 实用心脑肺血管病杂志,2023,31(9):64-69. [17] Liu X, Tao S, Ji H, et al.Risk factors for peripherally inserted central catheter (PICC)-associated infections in patients receiving chemotherapy and the preventive effect of a self-efficacy intervention program:a randomized controlled trial[J]. Ann Palliat Med, 2021, 10(9): 9398-9405. |